1509 / 1778
15
Take home messages
⚫
Elective lymph node target: 45-50Gy EBRT
Perspective of reducing morbidity with 45Gy
⚫
Pathological lymph nodes: 55-60Gy EBRT
Balance between tumour control and morbidity
⚫
Primary tumour (CTV
HR
):
>85-90Gy EBRT+BT
Balance between EBRT and BT
With more IC/IS BT it is possible to reduce EBRT dose to
45Gy
⚫
Overall treatment time:
<50 days